Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $5.5500 (-6.41%) ($5.3200 - $6.5700) on Fri. Sep. 18, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 9.15% (three month average) | RSI | 54 | Latest Price | $5.5500(-6.41%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR advances 3.1% a day on average for past five trading days. | Weekly Trend | CAPR declines -1.6% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) IGOV(47%) BWX(26%) TBT(23%) EDOC(17%) JNK(17%) | Factors Impacting CAPR price | CAPR will decline at least -4.575% in a week (0% probabilities). KWEB(-20%) UUP(-16%) MCHI(-16%) FXI(-16%) LQD(-10%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -4.575% (StdDev 9.15%) | Hourly BBV | 0.3 () | Intraday Trend | 0% | | | |
|
Inflection Point | Yes | 5 Day Moving Average | $5.26(5.51%) | 10 Day Moving Average | $4.97(11.67%) | 20 Day Moving Average | $5.23(6.12%) | To recent high | -43.4% | To recent low | 8.9% | Market Cap | $109m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |